Henry Hess | Chief General Counsel |
Reenie McCarthy | CEO |
Jim Carr | Chief Clinical Development Officer |
Brian Blakey | Chief Commercial Officer |
Rob Weiskopf | CFO |
Charles Duncan | Cantor Fitzgerald |
Matthew Luchini | BMO Capital Markets |
Yi Chen | H.C. Wainwright |
Greetings, and welcome to the Stealth BioTherapeutics First Quarter 2021 Earnings Call. At this time all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded. It is now pleasure to introduce Henry Hess, Chief General Counsel.